Pargluva Development May Be Terminated By Bristol, Merck
This article was originally published in The Pink Sheet Daily
Executive Summary
Regulatory approval and commercial success of the investigational type 2 diabetes drug will require additional clinical trials that could take up to five years to complete, Bristol says.